Anticipating designer drug-resistant cancer cells
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference31 articles.
1. Size matters: sequential mutations in tumorigenesis may reflect the stochastic effect of mutagen target sizes;Long;Genes Cancer,2011
2. Tumor adaptation and resistance to RAF inhibitors;Lito;Nat. Med.,2013
3. Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma;Monaghan-Benson;Oncogene,2013
4. Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1;Gromicho;Leuk. Lymphoma,2011
5. Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells;Wu;Biochem. Pharmacol.,2013
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, Synthesis, Computational Studies, and Anti-Proliferative Evaluation of Novel Ethacrynic Acid Derivatives Containing Nitrogen Heterocycle, Urea, and Thiourea Moieties as Anticancer Agents;Molecules;2024-03-23
2. An overview on the synthesis and anticancer properties of ethacrynic acid and their analogues;Results in Chemistry;2023-12
3. In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting;IRAN J BASIC MED SCI;2021
4. Synthesis and evaluation of a novel class of ethacrynic acid derivatives containing triazoles as potent anticancer agents;Bioorganic Chemistry;2021-10
5. Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes;Molecules;2018-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3